ePrints

Executive summary of the 12th HHT international scientific conference

Lookup NU author(s): Professor Helen ArthurORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

© 2017, Springer Science+Business Media B.V., part of Springer Nature. Hereditary hemorrhagic telangiectasia is an autosomal dominant trait affecting approximately 1 in 5000 people. A pathogenic DNA sequence variant in the ENG, ACVRL1 or SMAD4 genes, can be found in the majority of patients. The 12th International Scientific HHT Conference was held on June 8–11, 2017 in Dubrovnik, Croatia to present and discuss the latest scientific achievements, and was attended by over 200 scientific and clinical researchers. In total 174 abstracts were accepted of which 58 were selected for oral presentations. This article covers the basic science and clinical talks, and discussions from three theme-based workshops. We focus on significant emergent themes and unanswered questions. Understanding these topics and answering these questions will help to define the future of HHT research and therapeutics, and ultimately bring us closer to a cure.

Publication metadata

Author(s): Andrejecsk JW, Hosman AE, Botella LM, Shovlin CL, Arthur HM, Dupuis-Girod S, Buscarini E, Hughes CCW, Lebrin F, Mummery CL, Post MC, Mager JJ

Publication type: Article

Publication status: Published

Journal: Angiogenesis

Year: 2018

Volume: 21

Issue: 1

Pages: 169-181

Print publication date: 01/02/2018

Online publication date: 16/11/2017

Acceptance date: 02/04/2016

ISSN (print): 0969-6970

ISSN (electronic): 1573-7209

Publisher: Springer Netherlands

URL: https://doi.org/10.1007/s10456-017-9585-2

DOI: 10.1007/s10456-017-9585-2

Altmetrics

Share